CBD Use and Liver Injury: Practical Considerations for Primary Care - Frankly Speaking Ep 339
b'Credits: 0.25 AMA PRA Category 1 Credit\\u2122\\xa0CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339\\nOverview: In this episode, we dive into a recent systematic review and meta-analysis confirming the association between cannabidiol (CBD) use and hepatotoxicity. Gain a deeper understanding of clinical applications and the delicate balance of risks and benefits when discussing CBD use with your patients.\\nEpisode resource links:\\nLo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023 Mar 13. doi: 10.1111/joim.13627. Epub ahead of print. PMID: 36912195.\\nhttps://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf\\nGuest: Jillian Joseph, MPAS, PA-C\\xa0Music Credit: Richard Onorato'